Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women.

King AC, Cao D, O'Malley SS, Kranzler HR, Cai X, deWit H, Matthews AK, Stachoviak RJ.

J Clin Psychopharmacol. 2012 Oct;32(5):630-6. doi: 10.1097/JCP.0b013e3182676956.

2.

Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial.

Toll BA, White M, Wu R, Meandzija B, Jatlow P, Makuch R, O'Malley SS.

Drug Alcohol Depend. 2010 Oct 1;111(3):200-6. doi: 10.1016/j.drugalcdep.2010.04.015.

3.

Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial.

King AC, Cao D, Zhang L, O'Malley SS.

Biol Psychiatry. 2013 May 1;73(9):924-30. doi: 10.1016/j.biopsych.2012.09.025.

4.

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.

O'Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, Blakeslee A, Meandzija B, Romano-Dahlgard D, Wu R, Makuch R, Jatlow P.

Arch Intern Med. 2006 Mar 27;166(6):667-74.

PMID:
16567607
5.

Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences.

King A, de Wit H, Riley RC, Cao D, Niaura R, Hatsukami D.

Nicotine Tob Res. 2006 Oct;8(5):671-82.

PMID:
17008194
6.

Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study.

King A, Cao D, Vanier C, Wilcox T.

Alcohol Clin Exp Res. 2009 Jun;33(6):1044-50. doi: 10.1111/j.1530-0277.2009.00925.x.

7.

Naltrexone and nicotine patch smoking cessation: a preliminary study.

Krishnan-Sarin S, Meandzija B, O'Malley S.

Nicotine Tob Res. 2003 Dec;5(6):851-7.

PMID:
14750508
8.

The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation.

Walsh Z, Epstein A, Munisamy G, King A.

J Addict Dis. 2008;27(1):65-72. doi: 10.1300/J069v27n01_07.

PMID:
18551889
9.

Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.

Fridberg DJ, Cao D, Grant JE, King AC.

Alcohol Clin Exp Res. 2014 Oct;38(10):2622-9. doi: 10.1111/acer.12513.

10.

Naltrexone augments the effects of nicotine replacement therapy in female smokers.

Byars JA, Frost-Pineda K, Jacobs WS, Gold MS.

J Addict Dis. 2005;24(2):49-60.

PMID:
15784523
11.
12.

Effect of nicotine patch on energy intake and weight gain in postmenopausal women during smoking cessation.

Allen AM, Kleppinger A, Lando H, Oncken C.

Eat Behav. 2013 Dec;14(4):420-3. doi: 10.1016/j.eatbeh.2013.07.007.

13.

Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.

Anthenelli RM, Blom TJ, McElroy SL, Keck PE Jr.

Addiction. 2008 Apr;103(4):687-94. doi: 10.1111/j.1360-0443.2008.02148.x.

PMID:
18339115
14.

Naltrexone effects on short-term and long-term smoking cessation.

Covey LS, Glassman AH, Stetner F.

J Addict Dis. 1999;18(1):31-40.

PMID:
10234561
15.

An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects.

Wilcox CS, Oskooilar N, Erickson JS, Billes SK, Katz BB, Tollefson G, Dunayevich E.

Addict Behav. 2010 Mar;35(3):229-34. doi: 10.1016/j.addbeh.2009.10.017.

PMID:
19926400
16.

Weight change after smoking cessation using variable doses of transdermal nicotine replacement.

Dale LC, Schroeder DR, Wolter TD, Croghan IT, Hurt RD, Offord KP.

J Gen Intern Med. 1998 Jan;13(1):9-15.

17.

A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain.

Toll BA, Leary V, Wu R, Salovey P, Meandzija B, O'Malley SS.

Addict Behav. 2008 Jan;33(1):173-9.

18.

A randomized trial of naltrexone for smoking cessation.

Wong GY, Wolter TD, Croghan GA, Croghan IT, Offord KP, Hurt RD.

Addiction. 1999 Aug;94(8):1227-37.

PMID:
10615738
19.

Effects on smoking cessation: naltrexone combined with a cognitive behavioral treatment based on the community reinforcement approach.

Roozen HG, Van Beers SE, Weevers HJ, Breteler MH, Willemsen MC, Postmus PE, Kerkhof AJ.

Subst Use Misuse. 2006;41(1):45-60.

PMID:
16393735
20.

Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation.

Schnoll RA, Wileyto EP, Lerman C.

Addict Behav. 2012 Apr;37(4):565-8. doi: 10.1016/j.addbeh.2011.12.009.

Items per page

Supplemental Content

Support Center